3 completed, 1 recruiting, 1 terminated, 1 withdrawn. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Hot Flushes: new trials by email Literature Review of Hot Flushes trials Research Report on Hot Flushes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy fezolinetant - reference formulation, Placebo - Prostate Cancer, Prostate Cancer (Adenocarcinoma) | Phase 2 | Recruiting | Shehzad Basaria, M.D. | 60 | 2026-01-14 | 2026-08-17 |
| Stellate Ganglion Blockade in Post-Menopausal Women Stellate Ganglion Block Injection with Bupivicaine, Saline injection - Hot Flashes, Hot Flushes | Phase 2 | Withdrawn | Northwestern University | 2018-07-10 | 2025-07-23 | |
| Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer Stellate Ganglion Block injection with bupivicaine, Saline - Hot Flashes, Hot Flushes | Phase 2 | Terminated | Northwestern University | 2 | 2017-06-01 | 2022-08-09 |
| E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes) Estetrol, Placebo - Hot Flushes | Phase 2 | Completed | Donesta Bioscience | 260 | 2016-05-01 | 2024-11-18 |
| Stellate Ganglion Block (SGB) For Women for Breast Cancer Bupivicaine, Saline - Hot Flushes, Hot Flashes | Phase 2 | Completed | Northwestern University | 37 | 2015-07-01 | 2023-06-05 |
| Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease soy protein, isoflavones, Tamoxifen - Breast Cancer, Hot Flashes | Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 112 | 2002-03-01 | 2016-07-13 |
Hot Flashes (6) · Breast Neoplasms (2) · Adenocarcinoma (1) · Breast Carcinoma In Situ (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Multiple Endocrine Neoplasia Type 1 (1) · Prostatic Neoplasms (1)
Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Neoplasms (3) · Neoplasms by Site (3) · Breast Diseases (2) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Carcinoma in Situ (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Bupivacaine (3) · Sodium Chloride (3) · Estetrol (1) · Isoflavones (1) · Soybean Proteins (1) · Tamoxifen (1)
Northwestern University (3) · Alliance for Clinical Trials in Oncology (1) · Donesta Bioscience (1) · Shehzad Basaria, M.D. (1)
United States (5) · Belgium (1)
David R. Walega, MD, MSCI (2) · Charles W Hogue, MD (1) · Donesta Bioscience (1) · Gini F. Fleming, MD (1) · Shehzad S Basaria, MD (1)
2015 (1), U10CA076001 (1)